BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

NCT05161429 · clinicaltrials.gov ↗

UNKNOWN

Status

550000

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: DPP4
DRUG: GLP-1 receptor agonist
DRUG: Basal Insulin
DRUG: SLGT2
DRUG: SU

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]